Alternative corneal astigmatism measuring technique successful

Article

Corneal topographic astigmatism (CorT) is a successful alternative technique for measuring corneal astigmatism in irregular corneas.

Corneal topographic astigmatism (CorT) is a successful alternative technique for measuring corneal astigmatism in irregular corneas.

Dr Noel Aplins et al., NewVision Clinics, Melbourne, Australia, conducted a retrospective study on the CorT method by obtaining axial power measurements in the right and left eyes using topography.

The astigmatism value was calculated for each Placido ring and the ring astigmatism values were combined by vector summation to form a new measure named CorT.

CorT was compared with other commonly used measures of corneal astigmatism by ocular residual astigmatism (ORA) and its standard deviation (SD). The flat meridian of the CorTcan be employed to conceptually divide the cornea into two hemidivisions. This means a CorT value was calculated for each corneal hemidivision.

The findings revealed that CorT had better correlation with manifest refractive cylinder than manual keratometry, simulated K , corneal wavefront (ORA 0.74 ± 0.36 D) and paraxial curvature matching.

The abstract can be found in the Journal of Cataract and Refractive Surgery.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.